To study blood clotting in SCD because it is the most common cause of vascular death after a heart attack or stroke.
Testing Testing Testing Testing Testing Testing Testing Testing Testing Testing Testing Testing Testing Testing Testing
Testing Testing Testing Testing Testing Testing Testing Testing Testing Testing Testing Testing Testing Testing Testing
James Nichols, RN | |
(301) 755-7432 | |
jnichols@mail.nih.gov |
1 United States site
All SCD, SCT
Observational
Unknown
Individuals with sickle cell disease with and without Venous thromboembolism (VTE) should enroll if they:
Individuals with sickle cell trait
Ethnically matched controls
Individuals with sickle cell disease, do not enroll if you:
Individuals with SCT and ethnically matched controls